Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Jul-20 4:33 PM View:  | Meyer Ernie EVP and CHRO | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 10,330 | $18.00 | $185,940.00 | (100%) 10.33K to 0 | |
| 02-Jul-20 4:38 PM View: | Renton Hollings Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 13,194 | $18.00 | $237,492.00 | (57%) 23.3K to 10.11K | |
| 02-Jul-20 4:41 PM View: | Wolff Henry Ward Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 25,241 | $18.00 | $454,338.00 | (100%) 25.24K to 0 | |
| 02-Jul-20 4:29 PM View: | Johnson John H Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 20,475 | $18.00 | $368,550.00 | (100%) 20.48K to 0 | |
| 07-Jul-20 3:39 PM View: | Bird Jeffrey W Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 20,475 | $18.00 | $368,550.00 | (4%) 534.45K to 513.98K | |
| 02-Jul-20 4:28 PM View: | Garland J. Scott President and CEO Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 25,702 | $18.00 | $462,636.00 | (100%) 25.7K to 0 | |
| 02-Jul-20 4:38 PM View: | Renton Hollings Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 2,826 | $18.00 | $50,868.00 | (28%) 10.11K to 7.28K | |
| 02-Jul-20 4:32 PM View: | Love Ted W Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 15,575 | $18.00 | $280,350.00 | (100%) 15.57K to 0 | |
| 02-Jul-20 4:25 PM View: | Dier Mardi EVP and CFO | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 39,573 | $18.00 | $712,314.00 | (100%) 39.57K to 0 | |
| 02-Jul-20 4:24 PM View: | Brege Laura Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 20,475 | $18.00 | $368,550.00 | (100%) 20.48K to 0 | |
| 02-Jul-20 4:40 PM View: | Stump David C Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 20,475 | $18.00 | $368,550.00 | (100%) 20.48K to 0 | |
| 02-Jul-20 4:26 PM View: | Fenton Dennis M Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 20,475 | $18.00 | $368,550.00 | (100%) 20.48K to 0 | |
| 02-Jul-20 4:30 PM View: | Koenig Sheldon L. EVP, Chief Commercial Officer | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 5,563 | $18.00 | $100,134.00 | (100%) 5.56K to 0 | |
| 07-Jul-20 3:39 PM View: | Bird Jeffrey W Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 513,978 | $18.00 | $9,251,600.00 | (100%) 513.98K to 0 | |
| 02-Jul-20 4:22 PM View: | Brame Glenn P EVP, CTOO | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 8,533 | $18.00 | $153,594.00 | (100%) 8.53K to 0 | |
| 02-Jul-20 4:38 PM View: | Renton Hollings Director | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 7,281 | $18.00 | $131,058.00 | (100%) 7.28K to 0 | |
| 02-Jul-20 4:35 PM View: | Moriarty John B EVP, General Counsel | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 12,893 | $18.00 | $232,074.00 | (100%) 12.89K to 0 | |
| 02-Jul-20 4:28 PM View: | Garland J. Scott President and CEO Director | Portola Pharmaceuticals Inc (PTLA) | 18-Jun-20 | Grant | 1,173 | $8.36 | $9,806.28 | 100% 0 to 1.17K | |
| 02-Jul-20 4:25 PM View: | Dier Mardi EVP and CFO | Portola Pharmaceuticals Inc (PTLA) | 18-Jun-20 | Grant | 10 | $8.36 | $83.60 | 100% 0 to 10 | |
| 02-Jul-20 4:30 PM View: | Koenig Sheldon L. EVP, Chief Commercial Officer | Portola Pharmaceuticals Inc (PTLA) | 18-Jun-20 | Grant | 488 | $8.36 | $4,079.68 | 100% 0 to 0.49K | |
| 02-Jul-20 4:22 PM View: | Brame Glenn P EVP, CTOO | Portola Pharmaceuticals Inc (PTLA) | 18-Jun-20 | Grant | 1 | $8.36 | $8.36 | < 1% 0.88K to 0.88K | |
| 02-Jul-20 4:33 PM View: | Meyer Ernie EVP and CHRO | Portola Pharmaceuticals Inc (PTLA) | 18-Jun-20 | Grant | 789 | $8.36 | $6,596.04 | 100% 0 to 0.79K | |
| 15-Jun-20 7:06 PM View: | Love Ted W Director | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 88% 8.29K to 15.57K | |
| 15-Jun-20 6:49 PM View: | Brege Laura Director | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 55% 13.19K to 20.48K | |
| 15-Jun-20 7:15 PM View: | Stump David C Director | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 55% 13.19K to 20.48K | |
| 15-Jun-20 6:54 PM View: | Fenton Dennis M Director | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 55% 13.19K to 20.48K | |
| 15-Jun-20 7:10 PM View: | Renton Hollings Director | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 45% 16.02K to 23.3K | |
| 15-Jun-20 7:23 PM View: | Wolff Henry Ward Director | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 41% 17.96K to 25.24K | |
| 16-Jun-20 5:01 PM View: | Bird Jeffrey W Director | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 1% 527.17K to 534.45K | |
| 15-Jun-20 6:59 PM View: | Johnson John H Director | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 55% 13.19K to 20.48K | |
| 03-Mar-20 6:54 PM View: | Koenig Sheldon L. EVP, Chief Commercial Officer | Portola Pharmaceuticals Inc (PTLA) | 02-Mar-20 | Payment of Exercise | 4,327 | $9.68 | $41,885.40 | (10%) 42.32K to 37.99K | |
| 03-Mar-20 6:58 PM View: | Moriarty John B EVP, General Counsel | Portola Pharmaceuticals Inc (PTLA) | 02-Mar-20 | Payment of Exercise | 4,327 | $9.68 | $41,885.40 | (8%) 54.3K to 49.98K | |
| 03-Mar-20 6:51 PM View: | Dier Mardi EVP, CFO & CBO | Portola Pharmaceuticals Inc (PTLA) | 02-Mar-20 | Payment of Exercise | 4,543 | $9.68 | $43,976.20 | (5%) 82.77K to 78.23K | |
| 02-Jul-20 4:22 PM View: | Brame Glenn P EVP, CTOO | Portola Pharmaceuticals Inc (PTLA) | 28-Feb-20 | Grant | 881 | $8.59 | $7,567.79 | 100% 0 to 0.88K | |
| 02-Jul-20 4:33 PM View: | Meyer Ernie EVP and CHRO | Portola Pharmaceuticals Inc (PTLA) | 28-Feb-20 | Grant | 353 | $8.59 | $3,032.27 | 4% 9.19K to 9.54K | |
| 03-Mar-20 7:02 PM View: | Patni Rajiv EVP, CMO | Portola Pharmaceuticals Inc (PTLA) | 28-Feb-20 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K | |
| 04-Feb-20 6:54 PM View: | Garland J. Scott President and CEO Director | Portola Pharmaceuticals Inc (PTLA) | 03-Feb-20 | Payment of Exercise | 5,623 | $12.89 | $72,480.50 | (3%) 183.55K to 177.93K | |
| 04-Feb-20 6:48 PM View: | Brame Glenn P EVP, CTOO | Portola Pharmaceuticals Inc (PTLA) | 03-Feb-20 | Payment of Exercise | 2,075 | $12.89 | $26,746.80 | (4%) 52.64K to 50.57K | |
| 04-Feb-20 7:03 PM View: | Moriarty John B EVP, General Counsel | Portola Pharmaceuticals Inc (PTLA) | 03-Feb-20 | Payment of Exercise | 3,544 | $12.89 | $45,682.20 | (6%) 56.73K to 53.18K | |
| 04-Feb-20 6:51 PM View: | Dier Mardi EVP, CFO & CBO | Portola Pharmaceuticals Inc (PTLA) | 03-Feb-20 | Payment of Exercise | 3,435 | $12.89 | $44,277.20 | (4%) 84.97K to 81.53K | |
| 04-Feb-20 7:00 PM View: | Meyer Ernie EVP and CHRO | Portola Pharmaceuticals Inc (PTLA) | 03-Feb-20 | Payment of Exercise | 3,544 | $12.89 | $45,682.20 | (6%) 61.48K to 57.94K | |
| 04-Feb-20 7:00 PM View: | Meyer Ernie EVP and CHRO | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-20 | Grant | 16,250 | -- | -- | 36% 45.23K to 61.48K | |
| 04-Feb-20 6:57 PM View: | Koenig Sheldon L. EVP, Chief Commercial Officer | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-20 | Grant | 16,250 | -- | -- | 64% 25.27K to 41.52K | |
| 04-Feb-20 7:03 PM View: | Moriarty John B EVP, General Counsel | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-20 | Grant | 16,250 | -- | -- | 40% 40.48K to 56.73K | |
| 04-Feb-20 6:48 PM View: | Brame Glenn P EVP, CTOO | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-20 | Grant | 16,250 | -- | -- | 45% 36.39K to 52.64K | |
| 04-Feb-20 6:54 PM View: | Garland J. Scott President and CEO Director | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-20 | Grant | 50,000 | -- | -- | 37% 133.55K to 183.55K | |
| 04-Feb-20 6:51 PM View: | Dier Mardi EVP, CFO & CBO | Portola Pharmaceuticals Inc (PTLA) | 31-Jan-20 | Grant | 16,250 | -- | -- | 24% 68.72K to 84.97K | |
| 14-Jan-20 7:45 PM View: | Dier Mardi EVP, CFO & CBO | Portola Pharmaceuticals Inc (PTLA) | 14-Jan-20 | Payment of Exercise | 1,277 | $13.80 | $17,622.60 | (2%) 70.0K to 68.72K | |
| 14-Jan-20 7:45 PM View: | Dier Mardi EVP, CFO & CBO | Portola Pharmaceuticals Inc (PTLA) | 12-Jan-20 | Grant | 2,125 | -- | -- | 3% 67.87K to 70.0K | |
| 04-Nov-19 7:32 PM View: | Renton Hollings Director | Portola Pharmaceuticals Inc (PTLA) | 01-Nov-19 | Option Exercise | 5,000 | $9.00 | $45,000.00 | 31% 16.02K to 21.02K |
